#6 - Psychedelics and Mushroom Stocks
Nov 16, 2021•22 min•Season 1Ep. 6
Episode description
Psychedelics are about to disrupt big pharma. Public companies are producing new treatments for mental illness with psychedelic compounds, and this presents an interesting investment opportunity. We break down how this sector works, why we like it so much, and our top picks in the space.
For the best experience, listen in Metacast app for iOS or Android
